What happened
The Third Circuit on Tuesday partly revived academic cardiologist Dr. Norman Wang's lawsuit over the backlash to his article criticizing race-conscious policies in medical schools, residencies and fellowships, ruling that he plausibly alleged defamation against five defendants and raised triable retaliation issues.
The panel said the lower court was only partly right to toss the case. Wang had not plausibly alleged state action, the opinion said, but he had plausibly alleged that several defendants defamed him and that there were disputed facts over whether his employers retaliated against him for opposing allegedly unlawful discrimination.
Wang, a University of Pittsburgh professor and UPMC cardiologist, alleged that after he published a Journal of the American Heart Association article questioning race-based affirmative action in medical education and hospital training, his supervisors denounced the article as false and racist, amplified criticism on social media, removed him from a hospital-system program directorship and helped secure the article's retraction.
The court focused heavily on statements accusing Wang's article of misquotes, false interpretations and racist thinking. The panel said Berlacher's and Saba's tweets did more than state nonactionable academic disagreement because they accused Wang of misquoting and misreading data and sources, which the court treated as falsifiable claims. In the panel's words, the criticism was "more hit job than academic argument."
The opinion also said the American Heart Association's retraction notices and press release could be defamatory because they accused the article of misconceptions, misquotes, misstatements and selective misreading that stripped it of scientific validity. The panel concluded that much of Wang's defamation claim could proceed against Berlacher, Saba, the Association, the university and the hospital system, while claims against other defendants did not survive on the supplied spans.
On retaliation, the panel said there were factual disputes over whether Wang's employers acted against him for opposing what he described as illegal discrimination. The opinion recounted that Wang told Berlacher and Saba during the July 31 meeting that he wanted the graduate-medical-education program to follow the law, shortly before he was removed from his directorship and later barred from educational roles.
The decision drew a dissent on the defamation issue. The dissent argued that Wang had not shown actual malice, saying strong opposition to his views, failure to investigate and an alleged attack campaign did not establish that the speakers knew their statements were false or recklessly disregarded the truth.
The ruling sends significant parts of the dispute back for further proceedings and gives university, hospital and academic-publisher defendants a pointed appellate warning: criticism of controversial scholarship may be protected opinion, but accusations that an academic lied, misquoted sources or distorted evidence can carry defamation risk when framed as factual claims.